Merck Settles Vioxx Claims; WSJ Publishes Several Articles Discussing the Settlement

Although it is by now old news that Merck has reached a $4.85 billion settlement in the Vioxx litigation, the Wall Street Journal has several good articles on the settlement that interested readers should review:

- Merck Vioxx Settlement by the Numbers
- Vioxx Settlement Vindicates Merck's Tactics
- Vioxx Settlement's Next Big Question: Who Makes What?